Skip to content
HSA/FSA Eligible
60-Day Trial
Worldwide Shipping
Red light therapy for infectious diseases

Infectious diseases are illnesses caused by bacteria, viruses, parasites, or fungi that enter the body and multiply. Some stay near the surface, as cold sores and shingles blisters do, while others reach the lungs, the blood, or the immune system, as in tuberculosis, COVID-19, sepsis, and HIV. Antibiotics, antivirals, and other prescribed medicines remain the treatment for all of them. Red light therapy (RLT) has been tested alongside those medicines, and researchers propose that red and near-infrared light may support the immune response and speed the repair of infected tissue.

In this article, the efficacy of red light therapy has been evaluated for 12 infectious diseases, in this order: pneumonia, sepsis, tuberculosis, bacterial infection, leprosy, leishmaniasis, shingles, HPV, HIV, cold sores, hand-foot-and-mouth disease, and COVID-19. Every section opens with a definition, then sets out the human research and, where the Index has one, a verdict. Cold sores score highest at 87 out of 100 and hold the largest evidence base, 15 human studies across 1,035 participants. The unscored sections are more mixed: the HIV trial found no added advantage, and leprosy ulcers healed no faster with the light. Each scored section links to the full study list for that condition.

Our proprietary scoring system, the CURE Index, gives every condition a score once at least 3 human studies exist, so 4 of the 12 are scored, and the other 8 are reported study by study. Every study is rated Effective, Partially Effective, or Not Effective, and the Index weighs how strong each study is, how many exist, and how consistently they agree. All 4 scored conditions rate Effective, with 890 nanometers (nm), 632.8 nm, 1072 nm, 660 nm, and 808 nm used most among effective wavelengths. After the conditions, the questions turn to the light itself: how it acts on an infection, how to aim it, how often and for how long, and where its risks lie.

Infographic of red light therapy for infectious diseases, covering pneumonia, sepsis, tuberculosis, bacterial infection, leprosy, leishmaniasis, shingles, HPV, HIV, cold sores, hand-foot-and-mouth disease and COVID-19.

Pneumonia

Pneumonia is an infection that inflames the air sacs in one or both lungs and can fill them with fluid or pus. Bacteria, viruses, and fungi cause it, and bacteria are the most common cause in adults. It brings a cough with phlegm, fever, chills, chest pain, and shortness of breath. Young children, adults over 65, and people with weak immune systems or lung disease face the highest risk. Antibiotics clear most bacterial cases, yet cough, tiredness, and breathlessness can linger for weeks after the infection clears.

Researchers targeted red light therapy at that slow recovery. The method slides a low-intensity infrared laser across the skin of the chest, keeping it in contact as it moves over the lungs. The light is near-infrared, starting at 780 nm. Researchers chose the chest to aim the light at the lungs through the skin. They propose the light may improve blood flow through the lungs and support immune function. Given below is the evidence.

Lutaĭ, Egorova, and Shutemova tested that approach in older adults with pneumonia, publishing their report in 2001. The study compared 2 matched groups of patients aged 60 to 72. Both groups received routine pneumonia treatment, and one group had the infrared laser added. The team tracked symptoms, breathing function, blood flow through the lungs, and immune markers. Symptoms eased earlier in the laser group, and breathing and other function measures recovered more fully. The authors reported no side effects. They concluded that infrared laser therapy could be recommended for the rehabilitation of elderly patients with pneumonia.

Sepsis

Sepsis is the body’s extreme, life-threatening response to an infection. Instead of fighting the infection where it started, the immune system triggers inflammation throughout the body, which begins to damage organs. Lung infections, urinary infections, and infected wounds are the most common starting points. Sepsis brings fever or a low body temperature, a fast heartbeat, fast breathing, and confusion. Severe cases can progress to septic shock, a dangerous drop in blood pressure. Hospitals treat sepsis with antibiotics, fluids, and support for failing organs, yet it remains a leading cause of death in intensive care.

That body-wide inflammation is what researchers targeted with red light therapy delivered through the blood. The method, called vascular photobiomodulation, uses a red laser at 660 nm on the wrist, over the radial artery used to take a pulse. Each session lasts 30 minutes and delivers 180 J of energy, once a day. Researchers chose the artery so the light reaches blood flowing just beneath the skin rather than a single organ. They propose the light acts on circulating blood cells and may lower inflammation throughout the body. This is backed by one study.

In 2025, de Sousa and colleagues at Universidade Brasil in São Paulo, Brazil, published a randomized, blind, placebo-controlled trial in Lasers in Surgery and Medicine. 30 hospitalized patients with sepsis, mostly men with an average age of 40, were split between a control group and a group given the laser. The laser group received 1 session a day for 5 consecutive days. From the third day, the laser group showed a significant fall in white blood cell count, a marker of infection and inflammation. Lactate, a sign that tissues are short of oxygen, fell significantly, and so did creatinine, a marker of kidney strain. The authors reported significant changes in blood gas measures as well, including oxygen levels and blood acidity (pH). They concluded the laser improved clinical and blood markers of sepsis and described it as a promising option for managing the condition. However, the trial was small and lasted 5 days, and the abstract reports no survival, organ failure, or hospital stay outcomes.

Tuberculosis

Tuberculosis (TB) is a contagious bacterial infection that spreads through the air and settles mostly in the lungs and sometimes in other organs. People catch it by breathing in droplets from an infected person’s cough, and a weakened immune system raises the risk of illness. TB brings a lasting cough, fever, night sweats, and weight loss.

Red light therapy for tuberculosis earns an Effective verdict, 69 out of 100 on the CURE Index, inside the Moderate Confidence band. 3 human studies across 109 participants, each pairing the light with standard TB drugs, underpin the research on tuberculosis, and all 3 studies come back Effective. Included studies used 660 to 890 nm, and 890 nm was used most among effective wavelengths.

Bacterial Infection

A bacterial infection is an illness in which harmful bacteria enter the body and multiply faster than the immune system can clear them. The common entry routes are open wounds, surgical cuts, and infected teeth, with some bacteria reaching bone through the bloodstream. The infection brings fever, pain, and pockets of pus called abscesses.

The CURE Index scores red light therapy for bacterial infection at 67 out of 100 with an Effective verdict backed by Moderate Confidence. 212 participants across 3 human studies, where light was added to antibiotics or surgery, build the evidence on bacterial infection, and all 3 studies came back Effective. Wavelengths spanned 620 to 1400 nm, with 632.8 nm used most across the set.

Leprosy

Leprosy, also called Hansen’s disease, is a long-term bacterial infection caused by Mycobacterium leprae. It spreads through droplets from the nose and mouth during long, close contact with an untreated person, though most people are naturally resistant. The bacteria attack the skin and the nerves of the hands, feet, and face, causing pale numb patches, muscle weakness, and loss of feeling. Numb hands and feet are easily injured without the person noticing, and those injuries can turn into lasting ulcers. Multidrug therapy cures the infection, yet nerve damage and ulcers can continue for years afterward.

Red light therapy has been aimed at both of those lasting problems, the damaged nerves and the open ulcers. For the nerves, a pulsed near-infrared laser at 904 nm is held over each affected nerve for 9 seconds per point, at 70 mW, alongside a physiotherapy program. For the ulcers, a red laser at 660 nm and 40 mW is aimed at the wound bed and its edges, 3 times a week. Researchers chose these targets because nerve inflammation and slow wound healing cause most of the disability leprosy leaves behind. They propose the light may calm inflammation in the nerves, restore feeling and strength, and support tissue repair in the ulcers. This methodology comes from 2 studies.

In 2023, Duarte and colleagues at the Federal University of Mato Grosso (UFMT) in Cuiabá, Brazil, published a randomized controlled trial in Lasers in Medical Science. Patients with leprosy and neuritis, inflammation of the nerves, were split between a physiotherapy program alone and the same program combined with the 904 nm laser. On the SALSA scale, which rates limitations on everyday activities, the laser group improved from moderate to mild limitation, while the physiotherapy-only group stayed at moderate. Pain on a visual analog scale (VAS) fell significantly in the laser group. Nerve examination improved for the median, radial, and peroneal nerves. Strength improved in spreading the little finger and in lifting the foot at the ankle. Feeling improved in areas served by the ulnar and tibial nerves, and disability scores for the eyes, hands, and feet improved. All these changes were statistically significant against the physiotherapy-only group. The authors concluded that adding the laser to physiotherapy improved function and reduced pain.

However, an earlier trial on leprosy ulcers found no benefit. In 2010, Barreto and Salgado at the Dermato-Immunology Laboratory in Marituba, Pará, in the Brazilian Amazon, published a randomized clinical trial in BMC Infectious Diseases. The team first assessed 51 patients with leprosy-related ulcers (total 97 ulcers) that had been open for 97.6 months on average, about 8 years. 25 of these patients were then randomly assigned to the 660 nm laser or a control group, with treatment 3 times a week for 12 weeks. The trial measured ulcer area, ulcer depth, and the Pressure Ulcer Scale for Healing (PUSH) score. None of these measures changed significantly with the laser. The authors concluded that the laser added no benefit to ulcer healing at the settings used, and called for more effective treatments. However, only 25 patients entered the randomized stage, and the ulcers had been open for years before treatment began.

Leishmaniasis

Leishmaniasis is a parasitic disease spread by the bite of infected sand flies. Its most common form, cutaneous leishmaniasis, infects the skin, while other forms attack the nose and mouth or the inner organs. A small bump appears weeks after the bite and can grow into an open sore. Sores form most often on the face, hands, and legs, and can take months to heal and leave a scar. Standard treatment relies on painful antimony injections given over many clinic visits.

Red light therapy was tested as a needle-free option for those slow-healing sores. The method aims a red laser at 635 nm directly at each sore, at a low power of 300 mW. Each session delivers 75 J/cm², and sessions are given once a week. Researchers chose low-level light for its record in wound healing in other skin conditions. They propose that the mitochondria, the energy centers of skin cells, absorb the light and may use that energy to repair damaged tissue.

In 2020, Khan and colleagues at the Swat Institute of Nuclear Medicine Oncology and Radiotherapy (SINOR) in Pakistan published a pilot study in Dermatologic Therapy. 53 patients with cutaneous leishmaniasis, confirmed by a skin smear, had 123 sores between them. 47 patients had 113 early-stage sores, graded I and II. 6 patients had 10 advanced sores, graded III to V, with open ulcers or a secondary infection. Every patient received 4 weekly laser sessions. 103 of the 113 early-stage sores (91%) healed completely with a good cosmetic result. The other 10, all on the face, healed partly. The authors reported the early-stage response held at a 10-month follow-up. None of the 10 advanced sores healed fully with the laser. Those patients moved on to photodynamic therapy, which pairs the same light with a cream that makes the sore sensitive to it, and their sores healed after 3 sessions. Most patients rated pain during sessions as minor, and complaints of pain and burning eased with each session. Some had fever, peeling skin, or redness afterward, managed with supportive medicine. The authors concluded that early-stage sores may be treated with the laser, while advanced sores call for photodynamic therapy.

Shingles

Shingles, or herpes zoster, is a painful rash caused by the chickenpox virus waking up years after a first infection. The virus lies dormant in nerve roots, and age and a weakened immune system raise the chance it wakes. It follows one nerve, bringing burning pain and then a band of blisters on one side of the body. Near the eye or at the base of the spine, it can threaten sight or stop the bladder from emptying. Antiviral drugs shorten the illness if started early, yet the blisters can take weeks to heal, and the pain can linger.

Alongside those antivirals, researchers have aimed near-infrared light at the affected nerves and skin. On the face, an 830 nm LED device covers the forehead and nose, the area served by the nerve above the eye. Sessions last 10 minutes and are given 4 times over 10 days. At the base of the spine, 830 nm infrared light is given as physiotherapy over the sacral area. Researchers chose 830 nm because it passes through the skin and has a record in wound healing. They expect the light may speed skin repair and calm inflammation along the nerve. The evidence is with 2 studies explained below.

In 2013, Park and colleagues at Chung-Ang University College of Medicine in Seoul, Korea, published a pilot study in the Annals of Dermatology. 28 consecutive patients with shingles around the eye, called herpes zoster ophthalmicus, all took the antiviral famciclovir by mouth. 14 of them also received the 830 nm LED light on days 0, 4, 7, and 10. Blisters took 13.1 days on average to crust and heal with the light, against 15.9 days on the drug alone, a statistically significant difference. Pain scores improved more in the light group from day 4, though that difference fell short of statistical significance. The authors concluded the light led to faster wound healing and lower pain. However, the pilot was small, and the abstract does not describe the groups as randomized.

A 2018 case report from Jinling Hospital in Nanjing, China, published in the Nigerian Journal of Clinical Practice, described shingles in a rarer place. He and colleagues treated 2 patients whose shingles struck the sacral nerves at the base of the spine. Both lost the ability to empty the bladder, a condition called acute urinary retention. Both received a urinary catheter, the antiviral ganciclovir, and physiotherapy with 830 nm infrared light. Both recovered the ability to pass urine normally. However, the light was 1 of 3 treatments given together to 2 patients, so the report cannot show what it added.

HPV

HPV, the human papillomavirus, is a very common virus that infects the skin and the moist linings of the genitals, mouth, and throat. It spreads mainly through sexual contact. Most infections clear on their own within 2 years, but some persist for much longer. Low-risk types cause genital warts, while high-risk types can lead to cervical cancer over many years. Infections that cause no visible signs are called subclinical or latent, and no drug clears the virus itself.

Against those hidden infections, red light therapy has been paired with interferon, an antiviral drug that also boosts the immune response. The method shines red light at 625 nm onto the cervix and vagina for 20 minutes, at a low power of 7 to 10 mW. The light is given alongside interferon applied directly to the same area. Researchers combined the two to test whether the light adds to the drug’s effect. They propose the light may calm inflammation in the lining of the cervix and vagina and support the local immune response.

In 2018, Shi and colleagues at Ningxia Medical University General Hospital in Yinchuan, China, published a randomized clinical trial in Medicine. 90 women with subclinical or latent HPV infection were split into 3 groups of 30. One group received a low dose of interferon alfa-2b, 1 million international units (IU). A second group received a high dose of 9 million IU, and the third received the high dose plus red light, all once daily for 4 weeks. HPV was measured right after treatment and again at 4, 8, and 12 weeks. At every check, the high-dose and combination groups cleared the virus more often than the low-dose group, against both low-risk and high-risk types. Vaginitis and cervicitis, inflammation of the vagina and cervix, healed more often with the high dose than the low dose, and more often again when light was added. 3 of the 30 women in the combination group reported mild side effects. The authors concluded that high-dose interferon combined with red light was safe and effective against these infections.

HIV

HIV, the human immunodeficiency virus, attacks the immune system. It targets CD4 cells, the white blood cells that lead the body’s defense against infection. The virus spreads through blood, sexual contact, and from mother to child during pregnancy, birth, or breastfeeding. Without treatment, the loss of CD4 cells leads to AIDS (acquired immunodeficiency syndrome), the late stage that leaves the body open to serious infections. Daily antiretroviral therapy (ART) keeps the virus in check and can lower it to undetectable levels in the blood. In some people, though, the virus stays detectable, or CD4 counts recover slowly despite the drugs.

To push those slow responses further, red light therapy has been added to the drugs in a form aimed at the blood. The method is a needle-free version of intravenous laser irradiation of blood (ILIB). A red laser at 660 nm rests on the skin of the wrist, over the radial artery, for 30 minutes once a day. Each session delivers 180 J of energy. The artery runs close to the skin, so the light can reach the blood as it passes. Researchers propose that immune cells absorbing the light may lower the virus and raise counts of CD4 and CD8 cells, the 2 main types of T cells. One study already underpins this methodology.

In 2025, Ramos and colleagues at Universidade Estadual Paulista (UNESP) in Botucatu, Brazil, published a randomized, single-blind, sham-controlled trial in the Revista da Escola de Enfermagem da USP. 28 people living with HIV, all taking ART, were split between the laser (15) and a sham device that gave no light (13). Each group received 20 daily sessions. Viral load fell in both groups, by 1.7 log in the laser group and by 2.3 log with the sham, a log being a tenfold drop. CD4 counts did not rise, and CD8 counts fell slightly in the laser group without reaching significance. No outcome differed significantly between the groups, and the trial was stopped early at a planned interim analysis. The authors concluded the laser, added to ART, showed no clinical or statistical advantage on any immune or viral measure. However, stopping early left the trial small, so a modest effect cannot be ruled out.

Cold Sores

Cold sores, also called fever blisters, are small fluid-filled blisters on or around the lips. The common cause is herpes simplex virus type 1 (HSV-1), which stays dormant in the nerves after the first infection. Sunlight, stress, and illness wake the virus, and each outbreak brings tingling, painful blisters, then crusting scabs.

For cold sores, red light therapy stands at 87 out of 100 on the CURE Index, an Effective verdict under Strong Confidence. 15 human studies covering 1,035 participants have tested the red light on cold sores, and their outcomes split 13 Effective against 2 Partially Effective. Testing covered 650 to 1092 nm, and 1072 nm topped the effective wavelengths in the set.

Hand-Foot-and-Mouth Disease

Hand-foot-and-mouth disease (HFMD) is a common viral infection, most often caused by coxsackieviruses and other enteroviruses. It spreads through saliva, mucus, blister fluid, and stool, and mostly affects children under 5. It brings fever, a rash of small blisters on the hands and feet, and painful sores inside the mouth, called stomatitis. The mouth sores can make eating and drinking hard, which raises the risk of dehydration. There is no specific treatment, so care focuses on pain relief and fluids while the infection runs its course over 7 to 10 days.

Researchers have tested red light therapy on the mouth sores, the part of the illness that hurts most. The method aims a low-power near-infrared laser at 830 nm at the sores inside the mouth, at 30 mW. The light is pulsed at 30 Hz, and each sore receives 1.1 J/cm². Researchers chose the laser because it had already eased pain in other painful mouth conditions. They propose the light may calm the irritated nerves and inflammation in the sores. Below is the study behind it.

In 2003, Toida and colleagues at the Gifu University School of Medicine in Japan published a randomized, double-blind, placebo-controlled trial in Photomedicine and Laser Surgery. 20 patients with HFMD mouth sores were compared: 11 received the laser, and 9 received a placebo laser, with similar clinical backgrounds in both groups. Pain lasted 4.0 days on average in the laser group, against 6.7 days with the placebo, a statistically significant difference. 18 of the 20 patients (90%) found the treatment acceptable, and the authors observed no adverse events. They concluded the laser was a useful way to control HFMD mouth sores by shortening the painful period.

COVID-19

COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus, mostly attacking the lungs and airways. It passes between people through droplets and tiny airborne particles from coughs, sneezes, and talking. The disease brings fever, cough, breathlessness, and tiredness, and some people develop lasting problems with breathing, energy, and thinking.

Red light therapy was scored 85 out of 100 for COVID-19 by the CURE Index and rated Effective, with Strong Confidence. 14 human studies and 275 participants sit behind the score for COVID-19, and the outcomes are divided into 12 Effective and 2 Partially Effective. Trials tested 620 to 1070 nm, where 660 and 808 nm were used most among effective settings.

Does Red Light Therapy Work for Infectious Diseases?

Yes, for most of the conditions studied. Cold sores (87 out of 100), COVID-19 (85), tuberculosis (69), and bacterial infection (67) all rate Effective on the CURE Index. Across those trials, cold sores healed sooner, hospital patients with COVID-19 posted lower inflammation markers, tuberculosis bacteria cleared from phlegm faster, and fewer patients died of abdominal abscesses after surgery. Of the 8 conditions with only 1 or 2 studies, 7 recorded some gain, from faster-healing shingles blisters to closing leishmaniasis sores. Leprosy improved in the nerves, but not in the ulcers, and in HIV, viral load and immune counts moved no more than with a sham device.

From here, the answers move from mechanism to practice: how the light acts on an infection, how to aim it, and how often and how long to use it. The last two cover its risks, and whether Helio Cure panels run the wavelengths these studies tested.

How Does Red Light Therapy Work for Infectious Diseases?

Researchers propose red light therapy acts on the body’s response to an infection rather than on the germ itself. Cytochrome c oxidase, an enzyme in the mitochondria (the cell’s energy centers), absorbs red and near-infrared light and raises the energy available to immune and skin cells. In a 2022 lab study, de Castro and colleagues in Brazil found 660 nm light raised the ability of monocytes, a type of white blood cell, to kill Candida yeast. The light acts on runaway inflammation, and a 2022 COVID-19 trial in Iran recorded 3 inflammatory markers falling by 54% to 83%. It supports tissue repair too, and most trials aimed it at sores, ulcers, and wounds. Photodynamic therapy, which pairs light with a dye, is the method aimed at killing microbes, so trials on serious infections kept the standard drugs.

Diagram of how red light acts on the body's response to infection: the mitochondria absorb the light, immune and skin cells make more energy, white blood cells kill germs better, runaway inflammation calms and tissue repair speeds up at sores, ulcers and wounds.

How to Use Red Light Therapy for Infectious Diseases?

To use red light therapy for infectious diseases, aim the light at the skin where the infection shows, such as the lip for a cold sore, the rash for shingles, or an open sore. Clean and dry the area first, and wipe off thick creams or makeup, which can block part of the light. Face the light straight at the area and keep it close to the skin, so the beam covers the whole patch. Start at the first sign, such as the tingling or itching before a cold sore appears. Wear protective eyewear whenever the area is on the face. Keep taking prescribed medicines, and see a doctor first for shingles near the eye, a high fever, trouble breathing, or a serious infection such as tuberculosis.

Map of where to aim red light for infectious diseases: the face and the base of the spine for shingles; the lip and inside the mouth for cold sores and hand-foot-and-mouth disease; the wrist for sepsis and HIV; the chest for pneumonia; each sore for leishmaniasis; the hands and feet for leprosy; and the cervix and vagina for HPV.

How Frequently should You Use Red Light Therapy for Infectious Diseases?

The right answer on how often you should use red light therapy for infectious diseases depends on the infection. Fast-moving skin infections suit short, close-together sessions, while slow-healing sores suit a longer, spaced-out course. For example, a course for a cold sore can be 3- to 5-minute sessions, 1 to 3 times a day over 1 to 2 days, starting at the first tingle. However, the shingles trial gave 4 sessions of 10 minutes spread over 10 days, and the leishmaniasis trial 1 session a week for 4 weeks. Serious infections such as tuberculosis or COVID-19 require a doctor’s consultation first.

How Long Does Red Light Therapy Take to Act on Infectious Diseases?

In the trials on this page, results showed fastest on the skin. In the cold sore trials, pain eased sooner and the sore healed sooner than without light. Pain from mouth sores eased in about 4 days, and shingles blisters healed about 3 days sooner, at around 2 weeks. Slow-healing leishmaniasis sores closed over a course of 4 weekly sessions. Fewer repeat cold sores show over months, not days. Serious infections follow a doctor’s timeline, evaluated by tests rather than by how the skin looks. So it's wise to judge the result at the end of a full course, not after the first session.

Are there any Risks of using Red Light Therapy for Infectious Diseases?

Yes, there are a few risks of using RLT for infectious diseases, and the studies on this page reported only mild ones from the light. Those reported were redness, a burning feeling, or peeling skin where the light was aimed. The bigger risk is relying on the light alone in place of antibiotics, antivirals, or other prescribed medicines, since an untreated infection can spread. Some antibiotics can raise the skin’s sensitivity to light, and the eyes need protective eyewear. So it's best to visit a doctor before beginning red light therapy.

Do Helio Cure Panels Use the Wavelengths Studied for Infectious Diseases?

Yes, for several of them. Helio Cure panels run 630, 660, 810, 830, 850, and 1064 nm. The COVID-19 studies used 660 and 808 nm most, and the shingles and hand-foot-and-mouth disease trials used 830 nm, both panel settings. The bacterial infection studies used 632.8 nm most, close to the panels’ 630 nm. The cold sore studies cite 1072 nm, just above the panels’ 1064 nm, and the tuberculosis studies cite 890 nm, between the panels’ 850 and 1064 nm.


References

  1. https://pubmed.ncbi.nlm.nih.gov/14709221/
  2. https://pmc.ncbi.nlm.nih.gov/articles/pmid/40920044/
  3. https://pmc.ncbi.nlm.nih.gov/articles/pmid/30213012/
  4. https://doi.org/10.1111/dth.14232
  5. https://pmc.ncbi.nlm.nih.gov/articles/pmid/20698989/
  6. https://dx.doi.org/10.1007/s10103-023-03957-1
  7. https://pubmed.ncbi.nlm.nih.gov/11550371/
  8. https://doi.org/10.1002/lsm.70054
  9. https://pmc.ncbi.nlm.nih.gov/articles/pmid/23717006/
  10. https://pubmed.ncbi.nlm.nih.gov/29607871/
  11. https://link.springer.com/article/10.1007/s10103-020-03179-9

Thanks for subscribing!

This email has been registered!

Shop the look

Choose Options

Edit Option

this is just a warning
Login
Your Cart (0)